INFORMATION:
Adelson was the study's principal investigator for the New York Cancer Consortium. Study support included funding from National Cancer Institute/CTEP; and Millenium, the Takeda Oncology Company.
Contact: Vicky Agnew, Yale Cancer Center, 843-697-6208 or Vicky.agnew@yale.edu
Yale Cancer Center (YCC) is one of only 41 National Cancer Institute (NCI)-designated comprehensive cancer centers in the nation and the only such center in Connecticut. Comprehensive cancer centers play a vital role in the advancement of the NCI's goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment. http://www.yalecancercenter.org
New drug combination for advanced breast cancer delays disease progression
2014-12-10
(Press-News.org) New Haven, Conn. - A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6-9, by Kerin Adelson, M.D., assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale-New Haven.
The trial enrolled 118 post-menopausal women with metastatic hormone-receptor-positive breast cancer whose cancer continued to progress after being treated with an aromatase inhibitor. The study, based on work done by Doris Germain of Mt. Sinai Hospital, found that the combination of the drugs bortezomib and fulvestrant -- versus fulvestrant alone -- doubled the rate of survival at 12 months and reduced the chance of cancer progression overall.
Bortezomib, used most commonly in treating multiple myeloma, is a proteasome inhibitor that prevents cancer cells from clearing toxic material. Fulvestrant causes clumping of the estrogen-receptor protein. When bortezomib blocks the ability of the cell to clear these protein clumps, they grow larger and become toxic to the cancer cells. This, in turn, amplifies the effectiveness of fulvestrant, a drug commonly used in this subset of patients.
The drug combination doubled the number of patients whose cancer had not progressed after one year from 14% to 28%, according to Adelson.
"This provides the foundation for future studies combining selective estrogen-receptor destroyers with proteasome inhibitors," Adelson said. "Because the study showed a statistically significant benefit among patients whose disease progressed on an aromatase inhibitor, a larger phase III study comparing this combination to other approved therapies used after initial therapies fail, like exemestane and everolimus, should be done."
The study results also suggest that the drug combination can delay or overcome resistance to fulvestrant. The combination should be studied in other populations of patients, Adelson added, including those who are newly diagnosed with metastatic breast cancer and those who have already progressed on fulvestrant.
ELSE PRESS RELEASES FROM THIS DATE:
Most women with early-stage breast cancer in US receive radiation for too long
2014-12-10
PHILADELPHIA--Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicine researchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD. Their findings reveal that the vast majority of women after breast conserving surgery receive six to seven weeks of radiation therapy, despite multiple randomized trials and professional society guidelines showing that three weeks of radiation - called hypofractionated whole breast radiation - is just ...
Many breast cancer surgery patients do not receive shorter radiation treatment
2014-12-10
Although the use of a type of radiation treatment that is shorter in duration and less costly has increased among women with early-stage breast cancer who had breast conserving surgery, most patients who meet guidelines to receive this treatment do not, according to a study appearing in JAMA. The study is being released to coincide with the San Antonio Breast Cancer Symposium.
Breast cancer accounts for the largest portion of national expenditures on cancer care, estimated to reach $158 billion in 2020. Breast conservation therapy is the most common treatment for early-stage ...
CWRU scientists find key to vitamin A metabolism
2014-12-10
Researchers at Case Western Reserve University School of Medicine have uncovered the mechanism that enables the enzyme Lecithin: retinol acyltransferase (LRAT) to store vitamin A--a process that is indispensable for vision.
"Without this information, our knowledge was inadequate to understand the molecular mechanisms of blindness caused by mutations in the enzyme," said Marcin Golczak, assistant professor of pharmacology at Case Western Reserve and an author of the study.
The researchers hope the new information will be used to design small molecule therapies for degenerative ...
More meds, limited literacy reduces adherence to drug regimen by liver transplant patients
2014-12-10
New research reports that liver transplant recipients with less understanding of treatment information and improper use of medications may be more likely to have trouble following the prescribed regimen. According to the study published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, the patients' non-adherence is linked to adverse clinical outcomes, such as organ rejection or graft loss.
During the past 30 years, improvements in surgical techniques and advances in immunosuppressive ...
Study finds link between government healthcare spending and maternal mortality rates across the EU
2014-12-10
Reductions in government healthcare spending in the European Union (EU) are associated with increased maternal mortality rates, suggests a new paper published today (10 December) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG). However, if skilled birth attendants are in place, the association disappears, highlighting the potential importance of maternal care, finds the research.
The study looks at the association between reductions in government healthcare spending (GHS) and maternal mortality across the European Union (EU) over a 30 year period ...
Internet searches can predict volume of ER visits
2014-12-10
WASHINGTON - The correlation between Internet searches on a regional medical website and next-day visits to regional emergency departments was "significant," suggesting that Internet data may be used in the future to predict the level of demand at emergency departments. The first study to use Internet data to predict emergency department visits in either a region or a single hospital was published online Friday in Annals of Emergency Medicine ("Forecasting Emergency Department Visits Using Internet Data") .
"Website visits may be used to predict ER visits for a geographic ...
Honeybee hive sealant promotes hair growth in mice
2014-12-10
Hair loss can be devastating for the millions of men and women who experience it. Now scientists are reporting that a substance from honeybee hives might contain clues for developing a potential new therapy. They found that the material, called propolis, encouraged hair growth in mice. The study appears in ACS' Journal of Agricultural and Food Chemistry.
Ken Kobayashi and colleagues note that propolis is a resin-like material that honeybees use to seal small gaps in their hives. Not only does it work as a physical barrier, but it also contains active compounds that fight ...
Georgia State/CDC study: US taxpayers bear financial burden of smoking-related disease
2014-12-10
Cigarette smoking generates as much as $170 billion in annual health care spending in the United States, according to a new study co-authored by researchers at Georgia State University's School of Public Health, the Centers for Disease Control and Prevention (CDC) and RTI International.
Dr. Terry F. Pechacek, a professor of health management and policy at Georgia State, was the senior author of the study, "Annual Healthcare Spending Attributable to Cigarette Smoking (An Update)," which was published Wednesday by the American Journal of Preventive Medicine.
The study ...
New 'electronic skin' for prosthetics, robotics detects pressure from different directions
2014-12-10
Touch can be a subtle sense, but it communicates quickly whether something in our hands is slipping, for example, so we can tighten our grip. For the first time, scientists report the development of a stretchable "electronic skin" closely modeled after our own that can detect not just pressure, but also what direction it's coming from. The study on the advance, which could have applications for prosthetics and robotics, appears in the journal ACS Nano.
Hyunhyub Ko and colleagues explain that electronic skins are flexible, film-like devices designed to detect pressure, ...
CWRU nursing school develops how-to exercise pamphlet for people with MS
2014-12-10
Fatigue and pain, along with other symptoms, prevent many people with multiple sclerosis (MS) from exercising. But a new how-to guide for a home-based exercise program, tested by researchers at Case Western Reserve University's nursing school and the Lerner Research Institute at the Cleveland Clinic, offers a way for people with MS to stay more physically active.
The researchers developed a 24-week exercise program based on a series of pamphlets with varying levels of difficulty. The program helps inactive individuals start at a lower, shorter level of activity and gradually ...